• Corpus ID: 152256128

Mathematical models of the adaptive immune response in a novel cancer immunotherapy

  title={Mathematical models of the adaptive immune response in a novel cancer immunotherapy},
  author={Bryan A. Dawkins},
The immune system is the first line of defense against cancer. The immune system regularly detects and destroys cancer cells. Despite this continuous protection, certain cancers are able to escape detection or destruction by the immune system. Research in recent decades has addressed the possibility of enlisting the help of the immune system to detect and destroy cancer cells. One compelling treatment uses a laser, an immune stimulant called glycated chitosan (GC), and a light absorbing dye… 
1 Citations

Modeling for the body defense mechanisms in stage I melanoma patient and sensitivity analysis by using Partial Rank Correlation Coefficient (PRCC) method

: The scientific modeling of cellular growth and proliferation can significantly help to physicians to offer an appropriate treatment. In this paper the modeling of the body's immune system function



CD4 T Cells and Their Role in Antitumor Immune Responses

Charting the Th response against human melanoma as well as other tumors is important for the development of optimal anticancer vaccines and for the design of other T cell–related therapeutic modalities in cancer.

Cancer immunotherapy via dendritic cells

Dendritic cells are an essential target in efforts to generate therapeutic immunity against cancer owing to their ability to control both immune tolerance and immunity.

Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.

A mathematical model of cancer-immune interactions is presented that modifies generalized logistic growth with both immune-predation and immune-recruitment and predicts dormancy as a transient period of growth that necessarily ends in either tumor elimination or tumor escape.

A mathematical model of the dynamics of antitumor laser immunotherapy

This work uses a mathematical model to describe and predict the population dynamics of tumor cells, immune cells, and other immune components in a host undergoing laser immunotherapy treatment against metastatic cancer and finds that using strong immunoadjuvants that enhance dendritic cell activity yields more promising patient outcomes.

Antitumor immunity induced by laser immunotherapy and its adoptive transfer.

To further study the mechanisms of the antitumor immunity induced by laser immunotherapy, passive adoptive transfer was performed using splenocytes as immune cells using spleen cells that were harvested from successfully treated tumor-bearing rats and provided 100% immunity in the naive recipients.

Induced antitumor immunity against DMBA‐4 metastatic mammary tumors in rats using laser immunotherapy

The results show that laser immunotherapy could have potential for the treatment of metastatic tumors by inducing tumor‐specific, long‐lasting immunity and tumor regression and eradication and developed strong resistance to repeated challenges by tumor cells of the same type.

The Central Role of CD4+ T Cells in the Antitumor Immune Response

Analysis of the effector phase of tumor rejection induced by vaccination with irradiated tumor cells transduced to secrete granulocyte/macrophage colony-stimulating factor indicates a far broader role for CD4+ T cells in orchestrating the host response to tumor.

Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.

Results revealed the important function of the immunoadjuvant in laser immunotherapy and significantly reduced the growth of primary tumors and lung metastases in rats bearing metastatic prostate tumors.

Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.

This work reviews the individual sub-populations in regards to their mode of action and their potential impact on blocking anti-tumor immunity and describes possible ways to interfere with regulatory T cell-mediated immune suppression.

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles

This review focuses on discussion of the obstacles that oncolytic virotherapy faces and recent advances made to overcome them, with particular reference to adenoviruses.